Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis

…, A Perner, MW Petersen, J Savović, B Tomazini… - Jama, 2020 - jamanetwork.com
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are
needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced …

Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX …

BM Tomazini, IS Maia, AB Cavalcanti, O Berwanger… - Jama, 2020 - jamanetwork.com
Importance Acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19)
is associated with substantial mortality and use of health care resources. …

[HTML][HTML] Síndrome do desconforto respiratório agudo associada à COVID-19 tratada com DEXametasona (CoDEX): delineamento e justificativa de um estudo …

BM Tomazini, IS Maia, FR Bueno… - Revista brasileira de …, 2020 - SciELO Brasil
Objetivo: A infecção causada pelo coronavírus da síndrome respiratória aguda grave 2 (SARS-CoV-2)
disseminou-se por todo o mundo e foi categorizada como pandemia. As …

[HTML][HTML] Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study

…, CA Polanczyk, L Kawano-Dourado, BM Tomazini… - Intensive Care …, 2023 - Springer
Purpose To assess the association between acute disease severity and 1-year quality of life
in patients discharged after hospitalisation due to coronavirus disease 2019 (COVID-19). …

[HTML][HTML] Qualidade de vida e desfechos em longo prazo após hospitalização por COVID-19: Protocolo para um estudo de coorte prospectivo (Coalizão VII)

…, C Teixeira, FG Zampieri, BM Tomazini… - Revista Brasileira de …, 2021 - SciELO Brasil
Introdução: Os efeitos provocados pela COVID-19 em longo prazo são desconhecidos. O
presente estudo tem como objetivo avaliar os fatores associados com a qualidade de vida …

[HTML][HTML] COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial

BM Tomazini, IS Maia, FR Bueno… - Revista Brasileira de …, 2020 - SciELO Brasil
Objective: The infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
spreads worldwide and is considered a pandemic. The most common …

Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials

…, A Le Gouge, M Leclerc, J Savović, B Tomazini… - Trials, 2020 - Springer
Objectives Primary objective: To estimate the effect of corticosteroids compared with usual
care or placebo on mortality up to 28 days after randomization. Secondary objectives: To …

[HTML][HTML] Epidemiology, outcomes, and the use of intensive care unit resources of critically ill patients diagnosed with COVID-19 in Sao Paulo, Brazil: A cohort study

RL Socolovithc, RRL Fumis, BM Tomazini, L Pastore… - PLoS …, 2020 - journals.plos.org
Background The coronavirus disease (COVID-19) pandemic has brought significant challenges
worldwide, with high mortality, increased use of hospital resources, and the collapse of …

[HTML][HTML] Cerebral hemodynamics and intracranial compliance impairment in critically Ill COVID-19 patients: a pilot study

S Brasil, FS Taccone, SY Wayhs, BM Tomazini… - Brain sciences, 2021 - mdpi.com
Introduction: One of the possible mechanisms by which the new coronavirus (SARS-Cov2)
could induce brain damage is the impairment of cerebrovascular hemodynamics (CVH) and …

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

…, GW Wortmann, BM Tomazini… - The Lancet …, 2023 - thelancet.com
Background There is a clinical need for therapeutics for COVID-19 patients with acute
hypoxemic respiratory failure whose 60-day mortality remains at 30-50%. Aviptadil, a lung-…